Radiation Boost for Newly Diagnosed Glioblastoma Multiforme
Status:
Terminated
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine treatment related toxicity, tumor response,
progression-free survival and quality of life of newly diagnosed Glioblastoma Multiforme
(GBM) patients undergoing a combination of surgical resection, brachytherapy and external
beam radiation with concomitant temozolomide, followed by adjuvant temozolomide.